Accretion Pharmaceuticals

78.40
+0.45
(0.58%)
Market Cap
87.15 Cr
EPS
11.08
PE Ratio
12.76
Dividend Yield
0.00 %
Industry
-
52 Week High
82.95
52 Week Low
62.55
PB Ratio
1.92
Debt to Equity
2.46
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-162.79 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2024
TTM
Revenue
13
0
Expenses
11
0
EBITDA
3
0
Operating Profit %
20 %
0 %
Depreciation
0
0
Interest
1
0
Profit Before Tax
2
0
Tax
1
0
Net Profit
2
0
EPS in ₹
11.08
0.00

Balance Sheet

Balance Sheet
2024
Total Assets
27
Fixed Assets
5
Current Assets
22
Capital Work in Progress
0
Investments
0
Other Assets
22
Total Liabilities
27
Current Liabilities
15
Non Current Liabilities
7
Total Equity
6
Reserve & Surplus
2
Share Capital
4

Cash Flow

Cash Flow
2024
Net Cash Flow
0
Investing Activities
-6
Operating Activities
-11
Financing Activities
17

Share Holding

% Holding
Sept 2024
Jan 2025
May 2025
Promoter
100.00 %
100.00 %
73.50 %
FIIs
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
19.44 %
Others
0.00 %
0.00 %
7.06 %
No of Share Holders
8
8
8

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Jun 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jun 2025 66.05 69.80

Technical Indicators

RSI(14)
Neutral
45.72
ATR(14)
Less Volatile
4.22
STOCH(9,6)
Neutral
72.99
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
12.16
WillR(14)
Overbought
-17.88